Day: March 2, 2022

CINCINNATI, March 02, 2022 (GLOBE NEWSWIRE) — LSI Industries Inc. (NASDAQ: LYTS, or the “Company”), a leading U.S. based manufacturer of commercial lighting and display solutions, today announced that members of its executive management team will attend the 34th Annual Roth Conference which will be held March 14-15, 2022 at The Ritz Carlton in Dana Point, California. In conjunction with the event, LSI executives will be available to participate in live one-on-one meetings with institutional investors registered to attend the conference. For more information, please contact your Roth Capital salesperson. ABOUT LSI INDUSTRIES Headquartered in Greater Cincinnati, LSI is a publicly held company traded on the NASDAQ Stock Exchange under the symbol LYTS. The Company manufactures non-residential lighting and display solutions. Non-residential...

SXSW Will Leverage SpringServe’s Ad Serving Technology to Deliver High Quality Video Ad Experiences to Attendees NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) — SpringServe, the leading ad serving platform for connected TV (CTV), today announced a strategic collaboration with SXSW, to power inventory on their video on demand content, both online and on the SXSW TV apps. SpringServe’s advanced ad serving and inventory management technology helps publishers streamline their monetization to capture the full value of their inventory, all while ensuring high quality ad experiences. SXSW will leverage SpringServe to ensure high-quality in-app video advertising experiences for attendees. “We created SXSW TV to provide our audience with a premium viewing experience wherever they are. SpringServe’s industry-leading technology has allowed...

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced today that the Company will hold a conference call and webcast on March 14, 2022, at 9:00 a.m. EST to review fourth quarter and full-year 2021 financial results and provide a corporate update. To access the call, participants may join via a live webcast on the Investors and News section of the F-star Therapeutics website, under Events and Presentations. To join by phone, participants may dial the following numbers at least 10 minutes prior to the start of the call:US/Canada: 1-833-471-0868International: 1-914-987-7751United Kingdom: 800 0288438...

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces it has sold its Sculptura™ assets to Empyrean Medical Systems for $15 million in cash.  The sale, completed on February 25, 2022, included inventory of Sculptura™ systems and parts, in addition to all related intellectual property. “Sculptura will be in excellent, capable hands under the ownership of Empyrean, and we wish them all the best in their endeavors with this fabulous technology,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare....

CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that the Company will participate in a virtual panel presentation at the Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022 at 12:50 p.m. ET. A live webcast of the presentation will be available on the Investors & Media section of Mersana’s website at www.mersana.com. An archived replay will be available for approximately 30 days following the presentation. About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to rapidly develop...

TransUnion’s Consumer Pulse study reports increase in plans to reduce discretionary spending CHICAGO, March 02, 2022 (GLOBE NEWSWIRE) — Two in three Americans (64%) report being extremely or very concerned about inflation, according to TransUnion’s (NYSE: TRU) latest Consumer Pulse study. Nine in 10 (93%) expressed that they are at least slightly concerned. The results from the Feb. 7-15 survey of 2,949 adults were released today, just weeks after the Consumer Price Index – a measure of inflation – experienced its largest 12-month increase in 40 years at the end January. Six in 10 (62%) consumers say they are going to make changes to their purchasing behavior because of inflation. Of this group, 45% say they are going to decrease discretionary spending. In addition to inflation, grocery availability, new COVID-19 variants, product...

SEATTLE, March 02, 2022 (GLOBE NEWSWIRE) — Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, today announced that the company will participate in the Cowen 42nd Annual Health Care Conference taking place virtually from March 7-9, 2022. Adam Simpson, Chief Executive Officer of Icosavax, is scheduled to participate in the Infectious Disease corporate panel discussion on Wednesday, March 9, at 10:30 a.m. Eastern Time. Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.icosavax.com. The webcast replay will be available after the conclusion of the panel discussion for approximately 30 days. About Icosavax Icosavax...